About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 615 record(s)
Req # A-2022-00008
All documents and correspondences including, but not limited to briefing notes, scenario notes, information notes, meeting notes, emails, instant messages, reports, presentations, etc. relating to the CTA's released decision of July 12, 2022 stating that "crew shortages are to be considered within airlines' control for the purposes of the Air Passenger Protection Regulations, and that compensation is therefore owed to passengers affected by cancellations or delays due to crew shortages". Timeline July 12, 2022 to August 24 2022.Organization: Canadian Transportation Agency
August 2023
Req # A-2023-00234
I ask for copies of all Member complaints filed with respect to the Immigration Division from January 1, 2023 to May 25, 2023. I understand that identifying information will be redacted in compliance with the Privacy Act. Please also include any screening decisions or final decisions related to any complaints within the specified period.Organization: Immigration and Refugee Board of Canada
August 2023
Req # A-2023-00576
For the RPD, for each of the divisions, I would like to obtain the list of members and their level of bilingualism (oral, comprehension, and written)Organization: Immigration and Refugee Board of Canada
August 2023
Req # 52100-20-032-2022
Copies of contracts and paid out invoices for advertising and public relations agency services from Jan. 1, 2022 to presentOrganization: Vancouver Fraser Port Authority
August 2023
Req # 52100-20-021-2023
A copy of the Business Case assessment regarding the Pitt Meadows Road and Rail ProjectOrganization: Vancouver Fraser Port Authority
August 2023
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2023-00417
How many Afghan citizens were referred to detention reviews per fiscal year from 2020-2022 (inclusive)? Please also provide the grounds for each detention referral listedOrganization: Immigration and Refugee Board of Canada
July 2023
Req # A-2023-00430
For fiscal years 2020-2023 (inclusive), how much was the salary of the chauffeur for the Chair of the Refugee Board of Canada, Richard Wex, and how much of the Refugee Board of Canada’s annual budget did it represent? Please provide dollar figures and percentages.Organization: Immigration and Refugee Board of Canada
July 2023
Req # A-2022-05111
Electronic copies of the following documents. In all cases, cabinet confidences may be excluded and draft versions of documents. In all of the requests below, “draft guidelines” refers to the PMPRB Guidelines that were published for comment on October 6, 2022, or any prior drafts or versions of those 2022 Guidelines (for example, if a draft version was circulated to Health Canada for comment in September 2022, it would be part of the “draft guidelines” for the purpose of this request). • Emails or other communications from Health Canada commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Emails or other communications from the Board members or Board Chair commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Any training presentations, training manuals, or summaries of the new guidelines prepared for use by the Board Staff, Board, or other governmental departments prepared between July 1, 2022, and October 6, 2022. • Any documents with calculations of how much prices will decrease under the draft guidelines, or under alternative pricing rules, and that were prepared between January 1, 2022, and October 6, 2022 (note the change in date relative to other requests). • Any documents comparing prices or price reductions under the draft guidelines and the old PMPRB Compendium of Guidelines and Procedures. • Any documents, including legal memos, on the compliance of the draft guidelines with legal decisions about the PMPRB, including Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2021 FCA 157, Merck Canada c Canada, 2022 QCCA 240, and Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725. • Any documents which discuss how a medicine’s therapeutic class and comparator products will be established under the draft guidelines. • Any documents showing how the Board Staff arrived at the exact pricing tests discussed in paragraph 33-35 of the draft Guidelines. • Any documents which discuss how Board Staff will assess whether a price is excessive *after* an investigation has been opened. For context, the backgrounder which accompanied the draft guidelines suggested that staff will consider “the totality of the circumstances surrounding the price of the medicine, through the lens of the section 85 factors.Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025211
With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.Organization: Patented Medicine Prices Review Board Canada
July 2023